Comparison of Advanced Platelet Rich Fibrin Versus Platelet Rich Fibrin as a Gap Filling Material in Immediate Implant Placement
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Beni-Suef University
- Enrollment
- 16
- Locations
- 1
- Primary Endpoint
- Clinical evaluation
Overview
Brief Summary
Study type: Clinical Trial
Goal:
The goal of this clinical trial is to learn if Advanced Platelet-Rich Fibrin (A-PRF) versus traditional Platelet-Rich Fibrin (PRF) can improve bone healing and soft tissue outcomes in patients undergoing immediate dental implant placement.
Main questions it aims to answer:
Does A-PRF provide greater buccal bone preservation compared to PRF after immediate implant placement?
Does A-PRF improve soft tissue healing and reduce postoperative complications compared to PRF?
Comparison group:
Researchers will compare A-PRF to PRF as a gap-filling material in immediate implants to see if A-PRF results in better bone and soft tissue outcomes.
Participants will:
Undergo tooth extraction followed by immediate implant placement
Receive either A-PRF or PRF as the gap-filling material in the implant site
Have CBCT scans at baseline and 6 months to measure bone thickness
Have clinical assessments of soft tissue healing and implant stability
Attend follow-up visits at 1 week, 1 month, 3 months, and 6 months post-surgery
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •The selected patients has a badly decayed mandibular posterior teeth which are indicated for extraction due to dental causes (periapical abscess, trauma or caries) not periodontal as diagnosed by periapical x-ray.
- •Healthy patients who are classified according to the American Society of Anesthesiologists (ASA)(2022) physical status classification as class I.
- •Patient age ≥ 20 years old.
- •Surgical site with sufficient for implant placement.
- •Sufficient interocclusal space for prosthesis.
- •Good oral hygiene.
- •Patients have thick biotype.
- •Patients have socket class I.
Exclusion Criteria
- •Active periodontal diseases and periapical lesions not chronic infections.
- •Patients have parafunctional
- •History of alcohol or drug dependency, psychological factor that might affect the surgical or prosthodontic treatment.
- •Pregnant patients.
- •Patients who are not willing to complete the study.
Outcomes
Primary Outcomes
Clinical evaluation
Time Frame: 6 month
Implant stability will be measured by resonance frequency analysis (RFA) values expressed as implant stability quotient (ISQ) unit at 6 months post-operative
Secondary Outcomes
No secondary outcomes reported
Investigators
Eman Magdy Ahmed
Associate Professor
Beni-Suef University